Showing results (441-450 of 503) with videos related to

Sort By:
Pageof 51
Journal of Clinical Medicine|September 9, 2022
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic DermatitisNiccolò Gori, Andrea Chiricozzi, Franco Marsili, et al.
Clinical and Experimental Dermatology|April 15, 2026
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN StudyMarina Talamonti, Edoardo Mortato, Alessandra Narcisi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 15, 2021
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?Paolo Antonetti, Maria Concetta Fargnoli, Giampiero Porzio, et al.
International Journal of Cancer|June 12, 2014
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP projectElena Pasquali, José C García-Borrón, Maria Concetta Fargnoli, et al.
Dermatology and Therapy|September 24, 2024
Secukinumab in the Treatment of Psoriasis: A Narrative Review on Early Treatment and Real-World EvidencePiergiorgio Malagoli, Paolo Dapavo, Paolo Amerio, et al.
Dermatology and Therapy|February 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis)Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2019
Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)Celeste Lebbe, Claus Garbe, Alexander J Stratigos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2025
Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension studyMatthias Augustin, Marie Tauber, Robert Sidbury, et al.
American Journal of Clinical Dermatology|September 19, 2023
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment HistoryLuca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara-Pinton, et al.
Journal of the American Academy of Dermatology|January 21, 2021
The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patientsAngelo Valerio Marzano, Giovanni Genovese, Chiara Moltrasio, et al.
Pageof 51